Endo Pharmaceuticals Holdings Inc. (ENDP) reported third-quarter net income of $49 million compared to $66 million last year. Reported earnings per share were $0.42 compared to $0.55 last year.
Adjusted net income was $74 million compared to $79 million prior year. Adjusted earnings per share were $0.63 compared to $0.66 last year.
On average, 23 analysts polled by Thomson Reuters expected the company to report profit of $0.65 per share for the quarter. Analysts' estimates typically exclude special items.
Total revenues increased to $361 million from $317 million last year. Analysts expected revenue of $365.33 million for the quarter.
The company raised guidance for 2009 annual total revenues and adjusted earnings per share.
The company now estimates total revenues to be between $1.440 billion-$1.465 billion.
The company now estimates reported earnings per share to be between $1.41 and $1.47.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.